Home - GUNZE Medical USA

Bioabsorbable technology

with a touch of comfort built-in

QUALITY PRODUCTS

SOLUTIONS

WHY GUNZE?

Gunze's bioabsorbable medical materials provide comfort and relief post-surgery while enhancing regeneration and healing. Our customers in healthcare have confidence in a proven, trusted brand that has been a source of comfort and strength since 1896.

NEWS

Gunze Launches TENALEAF™ Absorbable Adhesion Barrier in Japan
tailored to medical professionals to improve patient clinical outcome

February 24, 2022 Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) is pleased to announce that…

Announcing the use of Gunze’s meniscal repair biodegradable scaffolds for a clinical trial to improve the outcome of medial meniscal injury patients at Osaka Medical and Pharmaceutical University

September 16, 2021 (Figure: Biodegradable scaffold for meniscal repair) 1. Background The meniscus is C-shaped cartilage…

Launch of Gunze’s U.S. Medical Division Website

We are excited to announce the launch of our new website!Gunze International U.S.A invites visitors to…

Gunze provides biodegradable scaffolds for TEVG clinical trial to be conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to improve pediatric patient clinical outcome

September 24, 2020 Figure: Biodegradable scaffold Gunze is pleased to announce that Gunze’s biodegradable scaffolds are…

Gunze Enters into Exclusive Supply and Distribution Agreement with Misonix for TheraGenesis® Bilayer Wound Matrix in U.S. Market

September 24, 2020 Gunze is pleased to announce that it has entered into an exclusive supply…

TESTIMONIALS

TISSUE ENGINEERED VASCULAR GRAFT
Angela’s Story

CHRISTOPHER K. BREUER, MD

"Here at Nationwide Children's Hospital, we have found that there may be a way to address and treat congenital heart disease in pediatric patients. The results from our work on Tissue Engineered Vascular Grafts are promising and we look forward to continuing to improve our patients' Quality of Life."